Editorial: is vedolizumab effective for perianal Crohn's disease?

Bella Ungar; Uri Kopylov

doi:10.1111/apt.15688

Editorial: is vedolizumab effective for perianal Crohn's disease?

Bella Ungar, Uri Kopylov^*

^*Corresponding author for this work

Internal Medicine

Research output: Contribution to journal › Editorial

1 Scopus citations

Original language	English
Pages (from-to)	912-913
Number of pages	2
Journal	Alimentary Pharmacology and Therapeutics
Volume	51
Issue number	9
DOIs	https://doi.org/10.1111/apt.15688
State	Published - 1 May 2020

Funding

Funders	Funder number
Abbvie Jannsen Takeda

Access to Document

10.1111/apt.15688

Cite this

@article{537d8b58baee463cbacf2f59218fc117,

title = "Editorial: is vedolizumab effective for perianal Crohn's disease?",

author = "Bella Ungar and Uri Kopylov",

note = "Funding Information: Declaration of personal interests: Bella Ungar received consultation fees from Janssen, Takeda, Neopharm and Abbvie. Uri Kopylov: lecture and advisory fees: Abbvie Jannsen Medtronic MSD Takeda Research support: Abbvie Jannsen Takeda.",

year = "2020",

month = may,

day = "1",

doi = "10.1111/apt.15688",

language = "אנגלית",

volume = "51",

pages = "912--913",

journal = "Alimentary Pharmacology and Therapeutics",

issn = "0269-2813",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "9",

}

TY - JOUR

T1 - Editorial

T2 - is vedolizumab effective for perianal Crohn's disease?

AU - Ungar, Bella

AU - Kopylov, Uri

N1 - Funding Information: Declaration of personal interests: Bella Ungar received consultation fees from Janssen, Takeda, Neopharm and Abbvie. Uri Kopylov: lecture and advisory fees: Abbvie Jannsen Medtronic MSD Takeda Research support: Abbvie Jannsen Takeda.

PY - 2020/5/1

Y1 - 2020/5/1

UR - http://www.scopus.com/inward/record.url?scp=85083378782&partnerID=8YFLogxK

U2 - 10.1111/apt.15688

DO - 10.1111/apt.15688

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.editorial???

C2 - 32285504

AN - SCOPUS:85083378782

SN - 0269-2813

VL - 51

SP - 912

EP - 913

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

IS - 9

ER -

Editorial: is vedolizumab effective for perianal Crohn's disease?

Funding

Access to Document

Other files and links

Cite this